Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20091012002576N34
IRCT20091012002576N34
Recruiting
Phase 2

Evaluation the effect of growth hormone (Gh) on pregnancy outcome of recurrent implantation failure (RIF) via intrauterine infusion.

Tehran University of Medical Sciences0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInfertility.Female infertility of other originN97.8

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Infertility.
Sponsor
Tehran University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •History of recurrent implantation failure due to unknown etiology
  • •Having good quality mbryo

Exclusion Criteria

  • •User of corticosteroids
  • •User of glucose control agents
  • •Uterine malformations
  • •Asherman syndrome
  • •Cavity distorting lesions
  • •Severe endometriosis
  • •Liver disease
  • •Severe male infertility
  • •Body mass index(BMI)\>30
  • •Uncontrolled hypothyroidism

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Growth hormone deficiency and clotting
ISRCTN59234325eeds Teaching Hospitals NHS Trust (UK)140
Completed
Not Applicable
The effects of growth hormone (GH) on the results of echocardiography in patients with heart failure (HF) four weeks after myocardial infarction (MI)
IRCT201704083035N1Vice chancellor for research, School of Medicine, Isfahan University of Medical Sciences32
Active, not recruiting
Not Applicable
A study to determine the effects of growth hormone (GH) replacement therapy on quality of life and cardiovascualr risk in GH deficient adults - Growth Hormone and Quality of Life (GroH-QoL)
EUCTR2004-004835-72-GBniversity of Birmingham200
Active, not recruiting
Not Applicable
Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with juvenile idiopathic arthritis (JIA) and growth failure. - rhGH in JIAGrowth retardation secondary to juvenile idiopathic arthritis
EUCTR2004-004153-25-GBRoyal Hospital For Sick Children, Yorkhill Division
Active, not recruiting
Phase 1
Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with Inflammatory bowel disease (IBD) and growth failure. - rhGH in IBD
EUCTR2004-002507-32-GBRoyal Hospital For Sick Children, Yorkhill Division60